REFERENCES
1. The future of the biological market. Business insights report. 2010 Mar. Available from:
http://www.globalbusinessinsights.com/
2. Carlson B. Biosimilar market fails to meet projections. Gen Eng Biotechnol News. 2009;29:43–5.
3. US Food and Drug Administration. CDER drug and biologic calendar year approvals. 2009 Dec 31. Available from:
http://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/DrugandBiologicApprovalReports/PriorityNDAandBLAApprovals/UCM090995.pdf 4.
4. European Medicines Agency. Available from: http://www.ema.europa.eu/ema
5. Walsh G. Biopharmaceuticals: approvals and approval trends in 2008. Biopharm Int. 2009;22(10):68–77.
6. Walsh G. Biopharmaceuticals: approval trends in 2007. BioPharm Int. 2008;21(10):52–65.
7. Walsh G. Biopharmaceuticals: approval trends in 2006. BioPharm Int. 2007;20(10):56–67.
|
